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Clinical proliles and erythrocyte Na transport abnormalities of four
major types of primary hypertension in Spain. The interaction of three
different Na transport systems (Na-K pump, Na-K cotransport
and Na-Li countertransport), with internal Na and the passive Na
leaks, were measured in erythrocytes from 72 Spanish, essential
hypertensive patients and 30 normotensive controls. According to the
observed abnormalities in Na transport pathways, 93.1% of the
patients were classified into the following subsets: 12 (16.7%) exhibited
a decreased apparent affinity of Na-K pump for internal Na (Pump
hypertensives); 20 (27.7%) showed a decreased apparent affinity
of Na-K cotransport for internal Na (Co '—" hypertensives); 27(37.5%) showed an accelerated Na-Li countertransport (Counter
"+" hypertensives); and 5 (6.9%) exhibited an increased rate constant
of passive Na leaks (Leak "+" hypertensives). Finally. 5 patients
(6.9%) did not show any abnormality in their Na transport systems and
3 exhibited more than one. Moreover, distinctive clinical features were
recognized in Co "—" and Counter "+" subsets. Blood pressure
values were lower in the former and, conversely, Counter +"
hypertensives showed a higher prevalence of moderate or severe
hypertension (65.5% vs. 32.6%; P = 0.0059) and higher values of
stimulated plasma renin activity (1.63 0.52 vs. 0.81 0.15; P =
0.0443). Our results confirm the heterogeneity of Na transport abnor-
malities in essential hypertension and suggest that these subsets of
hypertensives could represent clinical entities.
Much evidence has supported the hypothesis that essential
hypertension is an heterogeneous disease in its pathophysiolog-
ical mechanisms as well as in its clinical and therapeutical
considerations. The first and most important approach to the
heterogeneity of essential hypertensives was made by Laragh
[1], who classified them according to the level of plasma renin
activity (PRA). Moreover, he was able to detect differences in
clinical course and antihypertensive drug responsiveness in
relation to PRA levels.
In recent years, there has been a convincing evidence that
alterations in the intracellular pool of ions, specially Na and
Ca2, may play a role in the pathogenesis of essential hyper-
tension. Cellular metabolism of these cations are basically
mediated by transport proteins located in cellular membranes.
Several abnormalities of these transport pathways have been
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reported in red blood cells of essential hypertensives: an
increase in Na entry mediated by Na leak [2, 3], a decrease
in the apparent affinity of Na-K pump [4, 5] and Na-K
cotransport system [61 for internal Nat, and an enhancement of
Na-Li countertransport [7]. The prevalence of these abnor-
malities among the population of essential hypertensives basi-
cally depends on geographic and ethnic grounds. For instance,
the Na-K cotransport system has been found to be lower in
Blacks than in Caucasian hypertensives [8—10]. Moreover,
White hypertensives from USA seem to have a higher preva-
lence of accelerated Na-Li countertransport [71 than White
hypertensives from Europe [4] or Canada [11]. Likewise, some
clinical differences have been reported among them. All these
findings are in agreement with the hypothesis that essential
hypertension is an heterogeneous disease [12, 13].
On the basis of these previous considerations the aim of the
present study was to identify, in a kinetic approach, the
presence of different abnormalities of Na transport function in
erythrocytes from a Spanish population of essential hyperten-
sives. Likewise, we tried to distinguish possible differences in
clinical, biochemical and therapeutical aspects.
Methods
Patient selection
Seventy-two Caucasian hypertensive patients (39 males, 33
females) aged 29 to 75 years (mean 53) selected from the
Department of General Internal Medicine of the Hospital
Clinico (Barcelona, Spain) were included in this study. The
diagnosis of essential hypertension was considered on the basis
that no known cause of high blood pressure could be detected
after complete clinical, biochemical and radiological examina-
tion. None of the patients had renal impairment or papilloe-
dema. They had not received antihypertensive therapy for two
weeks before blood sampling. Pregnant women or those taking
contraceptive pills were excluded from the study.
A mercury sphygmomanometer was used to measure blood
pressure twice in succession, after a 10 minutes of rest in sitting
position, the arm supported on a cushion and the cuff at the
heart level. A standard adult cuff was used for most subjects
and a large cuff when it was required. Diastolic pressure was
recorded at the disappearance of the Korotkoff sounds (Phase
V). All readings were performed by the same nurse and using
the same manometer. Zero adjustment was checked daily and
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the instrument was serviced by the manufacturer every six
months.
Thirty normotensive controls (14 males, 16 females), aged 20
to 65 years (mean 46) were also included. Twenty-three of them
were members of the professional staff of the Hospital and
seven were healthy blood donors. Their blood pressure was
below 160/95 mm Hg on repeated examinations (mean 12 1/70)
and there was no known hypertension in any of their relatives.
Likewise, none of the women were pregnant or taking contra-
ceptive pills.
Methods
The measurement of Na efflux depending on four different
transport systems was done using previously described meth-
ods [14, 15].
Preparation of erythrocytes. Venous blood (30 ml) was
collected in heparinized tubes. After centrifugation at 1750 g for
10 minutes at 4°C, plasma and buffy coat were removed. One
aliquot of red cells was washed with MgCI2 110 mM and
maintained at 4°C until flux measurements were done. The
remaining red cell pellet was washed twice with 300 m sucrose
and resuspended in the same solution at a hematocrit of about
50%.
Na loading procedure. Four aliquots of cells containing
different Na concentrations were prepared for each subject
studied. Two ml of cell suspension were added to 20 ml of
loading media. These media were prepared by mixing suitable
amounts (4/0, 3/1, 1/3 and 0/4) of two phosphate solutions
containing (in mmollliter) 100 Na2HPO4 and 75 sucrose, and 100
K2HPO4 and 75 sucrose, respectively. The cell suspensions
were incubated at 37°C for 90 minutes renewing the loading
media every 30 minutes. Later, erythrocytes were resuspended
in 10 ml of a recovery medium prepared by mixing two solutions
containing (in mmol/liter) 150 NaCI or 150 KCI, 10 glucose, 10
______ ______
inosine, 5 adenine and 10 MOPS (4-morpholinopropane-sul-
fonic acid)-Tris (pH: 7.4 at 37°C). The cell suspensions were
incubated at 37°C for 80 minutes, renewing the recovery media
at 40 minutes.
Natloaded/depleted and intact erythrocytes were washed
five times in 100 MgCI2 at 4°C and resuspended to a packed cell
volume of 20 to 25% in a Mg2-sucrose solution containing (in
mmol/liter) 75 MgC12, 85 sucrose, 10 glucose and 10 MOPS-
Tris.
Measurement of internal Na content. One hundred micro-
liters of red blood cell suspension were hemolyzed with 10 ml of
bi-distilled water. Na and K were determined by atomic
absorption spectrophotometry and hemoglobin absorbance at
540.5 nm. The hemoglobin content per liter of loaded cells was
similar to that observed in untreated cells. This suggests that
there was no change in cell volume secondary to the loading
procedure.
Simultaneous measurement offluxes depending on the Na-
K pump, outward Na-K cotransport and Na-Li counter-
transport, and passive Na leak. One ml of each cell suspen-
sion was added in the cold to 4 ml of incubation media
containing Mg2-sucrose solution as a basic constituent plus
the following additions: 2 KCI (medium 1); 0.1 ouabain (medium
2); 0.1 ouabain and 0.02 bumetanide (medium 3); and 0.1
ouabain, 0.02 bumetanide and 10 LiCI (medium 4). They were
incubated at 37°C for 30 minutes (medium 1) or 60 minutes
(media 2, 3 & 4). For measuring external Na concentration
tubes were transferred to ice and centrifuged at 1750 g for four
minutes at 4°C. The supernatant was removed, thus avoiding
pellet contamination, and stored for Na concentration mea-
surement by atomic absorption spectrophotometry.
The Na flux depending on the Na-K pump (ouabain-
sensitive Na efliux) was estimated by the difference of Na
efflux in the presence (medium 2) and absence (medium I) of
ouabain. The Na flux depending on the outward Na-K
cotransport (bumetanide-sensitive Na efflux) was obtained by
the difference of Na efflux in media containing ouabain with
(medium 3) or without (medium 2) bumetanide. The Na flux
depending on the Na-Li countertransport (Li-stimulated
Na efflux) was estimated by the difference of Na efflux in
media containing ouabain and bumetanide in the presence
(medium 4) and absence (medium 3) of LiC1. The Na efflux in
medium 3 (ouabain, bumetanide-resistant Na efflux) was as-
sumed as the Na leak. Results were expressed in mol (liter
cells . hr)—l.
Calculation of maximal rate (Vmax) and apparent affinity for
internal Na (KNa) of the Na-K pump. For each subject
studied, ouabain-sensitive Na efflux was plotted as a function
of internal Na content. This sigmoidal function (S-shaped) can
be fitted by a modified Hanes equation [4]:
V = Vmax (1)(1 + KNa/[Na1)3
where Vmax is the maximal rate of ouabain-sensitive sodium
efflux, KNa represents the apparent dissociation constant for
internal Na, [NaJ is the internal Na cor tent and 3 is the
number of inner pump sites for internal Nat
Equation (1) can be rearranged as follows:
[Nal [Na] + KNa (2)lI3 j 1/3 V 1/3
max max
The left number of the equation (2) was plotted against [Nat]
by a Hanes graphic and a linear function was obtained. Vmax (in
imol (liter cells . hr)') and KNa (in mmol/liter cells) were
calculated by linear regression analysis from the slope and the
intersection with the abscissa, respectively.
The intracellular Na concentration required for half-max-
imal stimulation of Na-K pump (K50%) was obtained by the
equation:
max — max (3)
2 (1 + KN&[Na])3
Therefore:
K50% KNa/0.26 in mmollliter cells (4)
Calculation of Vmux and K50% of the outward Na-K
corransport. They were calculated using the same protocol as
the Na-K pump. The exponent 3 does not necessarily mean
that the Na-K cotransport has three inner sites for Nat
Equation (I) only describes a phenomenological function that
fits the sigmoidal dependence of outward cotransport fluxes as
a function of cell Na content.
Calculation Of Vma and K50% of Na -Li countertransport.
For each subject studied, Lit-stimulated Na efflux was also
plotted as a function of internal Na content. This function,
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Table 1. Values of the different kinetic parameters of Na transport
systems in 30 normotensive controls and 72 essential hypertensive
patients (mean SEM)
Normotensives Hypertensives
Na-K-ATPase
K50% 17.06 0.48 18.46 0.7!
'max 7424 267 8214 446
Na-K cotransport
K50% 12.06 0.75 15.09 1.01
'max 593 32 741 40
Na-Li countertransport
K50% 5.96 0.43 10.34 0.85
V0 214 9 75
Na leak (kNa) 22.04 1.19 27.27 1.68
K50% values are expressed in mmol/liter cells. Vm values are
expressed in smol (liter cells . hr) . kNa values are expressed in
l0— . hr.
a P = 0.0079
b P < 0.0001
which follows a typical Michaelian model, can be met by the
equation:
max
(I + KN5/[Na]) (5)
Vmax and KNa were also calculated by linear regression analysis
from the slope and the intersection with the abscissa, respec-
tively.
Calculation of the rate constant for Na leak (kNa). It was
calculated by dividing the ouabain-bumetanide resistant Na
efflux by the internal Na content and the results expressed in
(l0— . hr).
Statistical analysis
The Kolmogorov-Smirnov test was used to verify the nor-
mality of sample distribution. Differences in means were tested
by using the two-tailed Student's 1-test and one way analysis of
variance. When there was evidence of non-normality the Mann-
Whitney U-test and Kruskal-Wallis H-test were used to check
whether the samples came from the same population. Pearson's
chi square test was used to analyze the association between two
qualitative variables. The statistical analysis was performed by
means of BMDP Statistical Software [16] and SPSS Software
[17].
Results
Nor,notensive controls
The mean values of different kinetic parameters studied in 30
normotensive controls are shown in Table 1. None of these
parameters were influenced by age or sex.
Essential hypertensive patients
The mean values of kinetic parameters of Na-K pump,
NatK cotransport, Na-LP countertransport, and passive
Na leak are expressed in Table 1. Only Vmax and K50% of
Na-Li countertransport were significantly higher in hyper-
tensives than in normotensives: 375 24 versus 214 9
tmol. (liter cells . hr' (P <0.0001) for Vmax and 10,34 0.85
versus 5.96 0.43 mmol/liter cells (P 0.0079) for K50%.
Using 95% confidence limits in the normotensive group as the
Combined (42%)
Leak (6.9%)
Counter 0 (37.5%)
Null (6.9%)
Pump 0(16.7%)
Co 0 (27.8%)
Fig. 1. Distribution of Na transport abnormalities in the 72 essential
hypertensive patients.
normal range, 67 of the 72 hypertensive patients studied (93.1%)
exhibited some abnormality in their Na transport systems
(Fig. 1).
As it is shown in Table 2, twelve patients (16.7%) displayed
increased K50% values of the Na-K pump above the upper
normal limit of 22.22 mmol/liter cells (mean of this subset: 29.13
1.3 mmol/liter cells), revealing a decreased apparent affinity
of this transport system for internal Na (Pump "—"hyperten-
sives). The Vmax of Na-K pump was significantly higher in
this subset when compared with the remaining essential hyper-
tensives [13437 1285 vs. 7169 338 rmol . (liter cells .
P < 0.000 1] and 9 of them showed values clearly above the
upper normal limit of 10289 mol . (liter cells . hr)'.
Twenty patients (27.7%) exhibited increased K50% values of
outward Na-K cotransport above the upper normal limit of
20.11 mmol/liter cells (mean of this subset: 27.06 1.17; Co
—" hypertensives). The Vmax of outward cotransport was
increased in 9 patients, normal in 10 and decreased in 1, but
mean values of this subset were significantly higher than the
remaining essential hypertensives [968 88 vs. 654 38
mol . (liter cells . hr); P = 0.0013].
Twenty-seven patients (37.5%) presented an increased Vmax
of Na-Li countertransport above the upper normal limit of
305 imol . (liter cells . hr) (mean of this subset: 594 27;
Counter "+" hypertensives). The K50% of Na-Li counter-
transport was also increased in this subset when compared with
the remaining hypertensives (17.48 1.24 vs. 6.06 0.44
mmol/liter cells; P < 0.0001).
Five patients (6.9%) exhibited an increased rate constant of
Na leak above the upper normal limit of 34.87 (mean of this
subset 67.23 12.46 iO . hr; Leak "+" hypertensives).
Interestingly, Vmax of outward Na-K cotransport was signif-
icantly higher in this subset when compared with the remaining
essential hypertensive patients (1110 146 vs. 714 40
mol . (liter cells .hr); P = 0.0183). Finally, five patients
(6.9%) did not show any abnormality and three (4.2%) exhibited
more than one.
lntraerythrocytic Na + content
There were no differences in basal Na content among
subsets of essential hypertensives and the mean values were in
the normal range in all subsets.
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Table 2. Values (mean sEM) of the different kinetic parameters of Na transport systems in normotensive controls and the different subsets
of essential hypertensives, classified according to the main abnormality detected in the Na transport systems
Normotensives
N=30
Hypertensives
Pump "—"
N= 12
Co "—"
N=20
Counter "+"
N=27
Leak "+"
N=5
Na-K-ATPase
K50% 17.06 0.48 29.13 1.30 16.10 0.68 16.44 0.56 13.93 0.84
Vmax 7424 267 13437 1285 6999 433 6763 349 6276 751
Na-K cotransport
K50% 12.06 0.75 10.41 0.55 27.06 1.17 9.91 0.73 9.38 0.96
V,,ax 593 32 644 83 968 88 556 35 1110 146
Na-Li countertransport
1(50% 5.96 0.43 5.51 0.72 6.55 0.66 17.48 1.24 5.36 0.80
Vmax 214 9 240 12 234 12 594 27 266 22
Na leak (kNa) 22.04 1.19 23.55 2.09 22.78 1.18 23.81 1.20 67.23 12.46
K50% values are expressed in mmol/liter cells. values are expressed in mol . (liter cells . hr) . kNavalues are expressed in iO .hr*
Clinical aspects
No significant differences in age, sex, systolic, diastolic and
mean recorded blood pressure, age at the first diagnosis of
hypertension, number of given drugs, complications, body
mass index, urinary sodium excretion, plasma glucose, choles-
terol, triglycerides and renin activity were found when either
Pump "—" or Leak "+" hypertensives were compared with
the other subsets.
However, blood pressure values were significantly lower in
Co "—" hypertensives than in the remaining patients. Systolic
pressure was 162.4 3.0 versus 170.9 2.5 mm Hg (P =
0.0485), diastolic pressure was 100.9 1.4 versus 104.7 1.0
mm Hg (P = 0.0297) and mean pressure was 121.4 1.6 versus
126.4 1.3 mm Hg (P 0.0372). No differences were observed
in other clinical parameters.
Patients with increased Na-Li countertransport showed
mean values of diastolic blood pressure significantly higher than
the remaining essential hypertensives (106.1 1.4 versus 102.1
1.0 mm Hg; P = 0.0170). Likewise, patients included in this
subset showed a greater proportion of moderate or severe
hypertension (65.5% vs. 32.6%; P =0.0059). In the same way,
most Counter "+" hypertensives required two or more drugs
for blood pressure control (61.7% vs. 33.3%; P 0.0353).
These patients also exhibited values of stimulated plasma renin
activity (sPRA) after furosemide infusion higher than those of
the remaining subsets (1.63 0.52 vs. 0.81 0.15; P = 0.0443).
In fact the only three patients with high levels of sPRA fall into
the Counter "+" subset. No other differences were detected
between this subset and the remaining patients (Table 3).
Discussion
In recent years, several studies of Na transport in red blood
cells of essential hypertensives have confirmed the hypothesis
of DahI that an inborn error in Na metabolism plays a role in
the pathogenesis of essential hypertension [18]. It is now clearly
established that there is not a unique abnormality of Na
transport affecting the whole population of hypertensives. Ki-
netic studies have demonstrated this heterogeneity concerning
the abnormalities in Na transport systems [4, 11—13, 19].
These studies have revealed that erythrocytes from patients
with essential hypertension may exhibit one or more of the
following Na transport abnormalities: increased passive entry
Table 3. Clinical parameters of hypertension in the Counter "+"
subset and the remaining essential hypertensive patients
Counter "+" Other subsets
N=27 N=45 P
Age 50.7 2.39 54.5 1.52 NS
SBP 172.04 3.90 165.11 2.08 NS
DBP 106.11 1.37 102.11 0.97 0.0170
Glucose 108.81 8.03 104.45 4.31 NS
Cholesterol 244.69 9.63 231.84 6.20 NS
Triglycerides 120.77 13.48 130.74 10.73 NS
sPRA 1.63 0.52 0.81 0.15 0.0443
Aldosterone 15.74 1.10 14.94 1.26 NS
Abbreviations are: sPRA, plasma renin activity after furosemide
infusion; SBP, systolic blood pressure; DBP, diastolic blood pressure.
of Na into cells [2, 3], decreased apparent affinity of Na-K
ATPase for internal Na [4, 5], decreased apparent affinity of
outward Na-K cotransport system for internal Na [6] and
increased maximal rate of Na-Li countertransport [7]. The
prevalence of these abnormalities among hypertensives varies
in different studies and may be due to differences in erythrocyte
assay methods or it may reflect the marked heterogeneity of
essential hypertension.
The performance of kinetic studies of Na transport systems
implies the modification of intraerythrocytic Na content. In
most cases this has been done using the mercurial agent
PCMBS [4, 6, 7]. Nevertheless, this method may promote
countertransport fluxes inhibition [20]. Garay [15] has recently
described a new method that uses the physiological influx of
NaHPO4 through the anion carrier to modify the intracellular
Na concentration. Employing this experimental methodology
we studied four Na transport systems in a sample of 72
Spanish essential hypertensives. In 67 of them (93.1%) we
detected some abnormalities in their Na transport systems.
Twelve patients (16.7%) showed a decreased apparent affinity
of Na-K ATPase for internal Na (Pump "—" hyperten-
sives). This abnormality has been recently reported by Diez,
Hannaert and Garay [4] in 6 of 49 essential hypertensives
(12.2%). As well as in Diez study, the maximal rate of ouabain-
sensitive Na efflux was increased in our subset of Pump "—"
hypertensives. This rise in Vmax may be a compensatory
mechanism of the affinity defect to ensure a normal Na efflux
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in basal conditions. Thus, the measurement of ouabain-sensi-
tive Na effiux at a physiological Na content was not able to
detect this abnormality in most of the Pump "—" hyperten-
sives.
Twenty patients (27.7%) displayed a decrease in the apparent
affinity of the outward Na-K cotransport system for internal
Na (Co "—" hypertensives). The physiological function of
this transport pathway is not yet well established, but it seems
that at the physiological range of sodium, potassium, and
chloride in human red blood cells, the Na-K cotransport
system performs a net sodium extrusion [21]. A reduction in
furosemide-sensitive Na effiux was first noted in 1979 by
Garay and Meyer [22] in erythrocytes from patients with
essential hypertension. However, kinetic studies performed
later have shown some controversial findings. Hypertensive
patients have exhibited either normal [9] or decreased [4, 61
apparent affinity of Na-K cotransport for internal Na,
whereas the maximal rate of Na extrusion has been reported
decreased [6] or increased [9, 101. Our results are in agreement
with those of Garay et al [6] in the sense that some patients (Co
"—" hypertensives) exhibited a decreased apparent affinity of
Na-K cotransport system for internal Na, but differ in the
sense that maximal rate of bumetanide-sensitive Na extrusion
had a tendency toward higher values in our patients. The
prevalence of this abnormality of the apparent affinity in our
sample is closely related to that observed by Diez et al [4],
Twenty-seven patients (37.5%) exhibited increased maximal
rates of Na-Li countertransport system (Counter "+" hy-
pertensives), measured as Lit-stimulated Na efflux in Na
loaded erythrocytes. Most studies of Na-Li countertransport
have been performed measuring external Na-stimulated Li
effiux in Lit-loaded cells as described by Canessa et al [7].
Recently, Hannaert and Garay [23] have developed a new
method of measuring Na-Li countertransport using the ex-
ternal Li-stimulated Na effiux, and they have determined the
interindividual variations of the dissociation constants of inter-
nal Na and external Li sites. Na fluxes measured by this
method are less precise than those using the previous technique
of Canessa et at [7], but the method permits the simultaneous
measurement of Na-K ATPase and Na-K cotransport in
the same patient. Several studies have reported higher rates of
Na-LP countertransport in hypertensives with respect to
normotensives. However, the fraction of hypertensive patients
with elevated Na-Li exchange is extremely variable, ranging
from 10% to 90% [reviewed in 24, 25]. Many of these studies
varied in sample size and clinical criteria for hypertension and
there are also some methodological discrepancies. In recent
studies of Garay et al [4, 26] using a methodology similar to that
reported here, the prevalence of Counter "+" abnormality was
about 20%. Hypertensives with enhanced Na-Li counter-
transport represent the most numerous subset (37.5%) in our
sample. This may explain the significant differences in mean
values of the Vmax of Na-Li countertransport observed when
the whole samples of hypertensives and normotensives were
compared.
Finally, five patients (6.9%) presented increased values of
passive Na leak (Leak "+" hypertensives). This was the first
sodium transport abnormality reported by Wessels, Junge-
Hulsing and Losse in 1967 [2] and confirmed by more specific
studies [3, 27]. The control values of kNa obtained in the
present study are greater than those observed by Garay and
Nazaret [3]. This can be due in part to the fact that intraeryth-
rocytic Na content was significantly lower in our work. The
absolute ouabain- and bumetanide-resistant Na effiux was
similar in both studies, but if this value is divided by the Na
content to obtain kNa, then higher values of this parameter are
reached. Interestingly, the alteration of passive diffusion seems
to be compensated for by increases in the maximal rate of
outward Na-K cotransport, and this can explain the normal
Na content in these patients.
Neither the whole sample of hypertensives nor its different
subsets showed increases in internal Na concentration at basal
conditions. Wessels and Zumkley [28], who studied almost 300
essential hypertensives, showed a significant increase of 12% in
erythrocyte Na content in those patients. However, these
findings have not been corroborated in other studies and several
investigators have found a normal or even decreased [29] red
blood cell Na concentration [reviewed in 30, 31]. Normal
values of internal Na content observed in our study are
perhaps related to the presence of compensatory mechanisms in
Pump "—" and Leak "+" hypertensives.
We have not evidenced particular clinical features in patients
belonging to the Pump "—" or Leak "+" subsets. Neverthe-
less, this could be related with the relatively small number of
subjects exhibiting one of these abnormalities. Further investi-
gations are needed to elucidate if these subsets of essential
hypertensives actually represent clinical entities. Conversely,
the Co "—" and Counter "+" subsets, which are constituted
by a larger number of patients, display some distinctive features
regarding the severity of hypertension, number of drugs needed
for blood pressure control and plasma renin activity. This
suggests that subsets of essential hypertensives classified ac-
cording to the main defect of Na transport function may
represent clinical entities. Co "—" patients seem to be mild
hypertensives while Counter "+" patients appear to be the
most severe hypertensives.
The relationship between abnormalities of Na transport
function and the physiopathological mechanisms leading to high
blood pressure needs to be elucidated. In fact, an enhancement
of Na-Li countertransport could be an indicator of an
increased proximal Na reabsorption in kidneys. This has been
supported by Weder [32] in a recent work. He measured the
fractional Li clearance, which is thought to be an indicator of
proximal tubular Na reabsorption, and observed an inverse
relationship between the fractional Li clearance and red cell
Na-Li exchange. Weder concluded that these data provided
an indirect support for the hypothesis that an accelerated red
cell Na-Li exchange may be in fact a marker of an acceler-
ated Na-H exchange in the proximal tubule, causing an
enhancement of proximal Na reabsorption. Otherwise, the
abnormalities reported above may provoke a transitory in-
crease in intracellular Na content in vascular smooth muscle
cells or in noradrenergic endings. In vascular wall, Na trans-
port abnormalities may partially depolarize cell membranes,
thus opening potentially dependent Ca2 channels [33], or, they
may increase catecholamine output in noradrenergic endings
[34], thus opening receptor-dependent Ca2 channels. In addi-
tion, the extrusion of the excess in internal Na may stimulate
the Ca2-influx through Na-Ca2 countertransport [35]. The
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final result will be an increase in cytosolic free Ca2 content and
therefore in peripheral arterial resistance.
In conclusion, the results reported here strengthen the hy-
pothesis of Canessa et al [12, 13] in the sense that essential
hypertension is heterogeneous with respect to the abnormalities
of Na transport systems. Patients exhibiting a decreased
apparent affinity of the Na-K cotransport for internal Na or
an increased maximal rate of Na-Li countertransport display
some clinical hallmarks, suggesting that they may represent
separate clinical entities. The existence of separate clinical
profiles among essential hypertensives, supported by a molec-
ular basis, could have important prognostic and therapeutic
implications.
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